Drug Shortage Report for APO-RISPERIDONE
Report ID | 239819 |
Drug Identification Number | 02282143 |
Brand name | APO-RISPERIDONE |
Common or Proper name | RISPERIDONE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | RISPERIDONE |
Strength(s) | 2.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 BTL |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-10-08 |
Estimated end date | 2025-01-10 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-10-31 |
Company comments | 100 BTL available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-10-31 | French | Compare |
v3 | 2024-10-31 | English | Compare |
v2 | 2024-10-10 | French | Compare |
v1 | 2024-10-10 | English | Compare |
Showing 1 to 4 of 4